Browsing: GLP1

There is a beautiful stupidity in the next great innovation of the food industry: food designed to make us want less food. Capitalism has finally eaten itself, and now it’s complaining that it feels a bit full

1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention

The Trump administration has officially launched its new “bridge” model that brings GLP-1 coverage for weight loss to Medicare beneficiaries

A recent Gallup poll reveals a significant increase in the use of GLP-1 medications for weight loss among Americans. As of 2026, 11% of Americans are using these drugs, a notable rise from just 3% in 2024. This surge in usage is linked to a gradual decline in the U.S. adult obesity rate, which has…

The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there’s a catch when it comes to bone health

With the proliferation of telehealth websites, Yale researchers were curious how much oversight is required to get GLP-1 weight-loss drugs. To find out, one of the researchers, posing as an overweight man, started shopping around

Partners Hengrui Pharma and Kailera Therapeutics revealed Tuesday that two China-based late-stage trials evaluating an investigational small molecule GLP-1 receptor have hit their main goals, prompting Hengrui to tee up plans for regulatory submission in the Asian country

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposures reported to U.S. poison centers increased following 2021 U.S. Food and Drug Administration (FDA) approval for weight loss, according to a study published in the April issue of the Journal of Medical Toxicology

What began as a treatment for type 2 diabetes has rapidly evolved into one of the biggest shifts in modern healthcare. New data suggests that GLP-1 medications, popularly associated with brands such as Ozempic and Wegovy, are no longer confined to celebrity headlines or specialist clinics but have entered the mainstream

GLP-1 medications, with brand names such as Ozempic, Wegovy, and Zepbound, regulate blood sugar in people with type 2 diabetes and are also used for weight loss. Over the years, studies have shown them to be safe and effective when taken as prescribed